RA Capital Nexus Fund II, L.P., Director, 10% Owner at LENZ Therapeutics, Inc. (LENZ), bought 129,942 shares at $15.03 ($2.0M) on 2024-03-21, disclosed to the SEC on 2024-03-25.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $15.03 | 64,971 | $977K | 50.0% |
| 2 | $15.03 | 64,971 | $977K | 50.0% |
| Total | $15.03 avg | 129,942 | $2.0M | 100% |
| Filing → |
| JANX | BUY | 2023-07-21 | $12.3M | — | Filing → |
| DICE | BUY | 2023-03-30 | $29.6M | — | Filing → |
| ANTX | BUY | 2022-07-28 | $361K | — | Filing → |